logo
Share SHARE
FONT-SIZE Plus   Neg

Oaktree Prices IPO Of 8.84 Million Class A Unit At $43, At Bottom End Of Range

Oaktree Capital Group, LLC global investment management firm focused on alternative markets, announced the pricing of its initial public offering of 8.84 million shares at $43.00 per Class A unit, the bottom of the proposed range.

Of the Class A units to be sold in the offering, Oaktree is offering 7.89 million Class A units and the selling unitholders are offering 954 thousand Class A units.

In an amended regulatory filing with the U.S. Securities and Exchange Commission, the company had expected to offer 11.25 million units at $43 to $46 per share.

Oaktree's Class A units will begin trading on the New York Stock Exchange under the symbol "OAK" on April 12, 2012.

In addition, the underwriters have been granted a 30-day option to purchase up to an additional 1.18 million Class A units from Oaktree and 143 thousand Class A units from the selling unitholders.

The Los Angeles-based asset manager said it will not retain any of the proceeds from the sale of Class A units by the selling unitholders and will use its offering proceeds to acquire interests in the company's business from Oaktree's principals, employees and other investors.

Goldman, Sachs & Co. and Morgan Stanley are acting as joint global coordinators and BofA Merrill Lynch, Credit Suisse, Deutsche Bank Securities and J.P. Morgan are acting as joint bookrunners for this offering.

Oaktree had $74.9 billion in assets under management as of Dec. 31, down from $82.7 billion a year earlier.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT